Financial News
Latest News about AMGN
Recent news which mentions AMGN
Only 47 stocks in the S&P 500 have fallen over the past year — Wall Street predicts they will climb up to 54% in 12 months
September 28, 2021
From MarketWatch
Better Buy: Amgen or All 30 Dow Jones Stocks?
September 28, 2021
From Motley Fool
3 Biotech Stocks That Could Make You Filthy Rich
September 27, 2021
From Motley Fool
Amgen's Repatha Scores FDA Nod For Pediatric Patients Over 10 Years With Inherited Heart Disease
September 27, 2021
Tickers
AMGN
From Benzinga
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
September 27, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
From Benzinga
Where to Invest $100 Right Now
September 22, 2021
From Motley Fool
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
From Benzinga
Why Verastem Stock Spiked Today
September 20, 2021
From Motley Fool
Penny Biotech Stocks: 8 Things for Verastem Investors to Know as VSTM Stock Shoots Higher
September 20, 2021
From InvestorPlace
Here are the worst-performing U.S. stocks as the Evergrande crisis rattles investors
September 20, 2021
From MarketWatch
Apple And Microsoft Lead The Dow Jones Lower
September 17, 2021
From Benzinga
This Dow Jones Stock Could Double Your Money
September 17, 2021
From Motley Fool
Is AbbVie's 4.9% Dividend Yield Safe?
September 15, 2021
From Motley Fool
3 Top Chinese Stocks to Watch in September
September 15, 2021
From Motley Fool
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
September 11, 2021
From Motley Fool
Amgen Reveals Post-Hoc Data For Its KRAS Inhibitor In Lung Cancer Patients
September 09, 2021
Tickers
AMGN
From Benzinga
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?
September 09, 2021
From Motley Fool
Downgrades On Economy And Pandemic Pharmaceuticals
September 08, 2021
From Benzinga
3 Beaten-Up Stocks for Bargain Hunters
September 08, 2021
From Motley Fool
Disney And Apple Lead The Dow Jones
September 07, 2021
From Benzinga
Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley
September 07, 2021
From MarketWatch
Amgen, AstraZeneca Tout Additional Data From Asthma Trial With Tezepelumab
September 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
September 07, 2021
From Benzinga
14 dividend stocks from a winning value manager as the broader market hits record highs
September 03, 2021
From MarketWatch
Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks in August?
September 02, 2021
From Motley Fool
Atossa Therapeutics Has a Steep Climb Ahead of It
August 31, 2021
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.